Table 3 Results of GSEA gene set enrichment analysis between IDD and control groups in combined datasets.
ID | Set Size | Enrichment Score | NES | P value | p.adjust | Q value |
|---|---|---|---|---|---|---|
KIM_WT1_TARGETS_DN | 416 | 0.4509278 | 1.864365 | 1.02 e-10 | 5.39 e-07 | 4.72 e-07 |
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 326 | 0.4767721 | 1.921217 | 6.35 e-10 | 1.67 e-06 | 1.47 e-06 |
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 238 | 0.5088824 | 1.988975 | 1.82 e-09 | 3.2 e-06 | 2.8 e-06 |
NAGASHIMA_NRG1_SIGNALING_UP | 163 | 0.5485680 | 2.063942 | 3.24 e-09 | 4.27 e-06 | 3.74 e-06 |
WANG_SMARCE1_TARGETS_UP | 200 | 0.5138466 | 1.957534 | 1.32 e-08 | 1.4 e-05 | 1.22 e-05 |
VERHAAK_AML_WITH_NPM1_MUTATED_UP | 160 | 0.5351318 | 1.965982 | 4.99 e-08 | 3.84 e-05 | 3.36 e-05 |
JAEGER_METASTASIS_DN | 235 | 0.4819628 | 1.889095 | 5.83 e-08 | 3.84 e-05 | 3.36 e-05 |
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP | 378 | 0.4335381 | 1.776046 | 5.16 e-08 | 3.84 e-05 | 3.36 e-05 |
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 127 | 0.5727855 | 2.027521 | 8.32 e-08 | 4.88 e-05 | 4.27 e-05 |
ONDER_CDH1_TARGETS_2_UP | 239 | 0.4829889 | 1.895050 | 1.4 e-07 | 7.4 e-05 | 6.47 e-05 |
FOROUTAN_INTEGRATED_TGFB_EMT_UP | 118 | 0.5058604 | 1.783987 | 5.13 e-05 | 3.82 e-03 | 3.35 e-03 |
WEINMANN_ADAPTATION_TO_HYPOXIA_DN | 34 | 0.6808293 | 1.928060 | 1.39 e-04 | 7.79 e-03 | 6.82 e-03 |
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 413 | 0.3475608 | 1.434159 | 5.02 e-04 | 1.85 e-02 | 1.62 e-02 |
WP_IRON_METABOLISM_IN_PLACENTA | 10 | 0.8364089 | 1.832610 | 1.37 e-03 | 3.38 e-02 | 2.96 e-02 |
